A NEW BEGINNING IS ON THE HORIZON...

America’s REBIRTH
Coming Any Day Now

The U.S. government just backed a firm that could hold the keys to ENDING the pandemic. As they decide next steps, the coming days could change the lives of 328 million Americans...

Giving you the chance to make 3,000% in record time.

It's official...

The U.S. economy is finally starting to reopen.

Life is finally starting to return to normal.

But the coronavirus is NOT defeated.

Q_01

The only way out of this pandemic...

Is if we can create a vaccine.

Dr. Anthony Fauci – the infectious disease expert who's been on TV more than the president – says a vaccine would be "the ultimate game changer."

Q_02

And he's absolutely right.

But like any drug...

Getting a vaccine into the world isn't easy.

First, it has to be developed...

Then it has to go through the FDA's rigorous five-stage approval process.

IMG_01

But as you know...

Life is anything but normal right now.

But it's for this very reason that...

The Rules Have Changed.

Rather than the long and tedious FDA approval process that a vaccine would normally have to go through...

The FDA has just issued a policy that will expedite this entire process exponentially.

Why should you care? Three reasons...

  • Number one...

    When a COVID-19 vaccine makes its way into the public sphere, you'll likely be injecting it into your body.
  • Number two...

    This vaccine is going to arrive MUCH sooner than anyone thinks. I'll tell you how I know that in a second.
  • Number three...

    If you support the company that's racing to develop this vaccine NOW – before it makes its final push towards worldwide distribution...

You're not just looking at the potential for a few hundred percent gains...

You're Looking at Potentially Making 3,000% Gains or More.

Normally, I would NEVER – in a million years – make an outrageous claim like that. 

But when it comes to producing giant gains...

Biotech stocks always win the day!

Just look at Aquinox Pharmaceuticals.

C_01_AQXP

This biotech stock was working on a VERY niche treatment for bladder pain.

The total market was only about $427 million.

But that didn't stop this stock from soaring 1,175%.

Then there's Questcor.

This company was working on rare autoimmune disorders.

Just by tapping into uncommon markets like dermatomyositis, the company swelled like a hot air balloon, going up 18,143%.

C_02_QCOR

These were some of the most incredible gains we've seen across the entire stock market in the past decade.

Most investments will only get you about a 7% return each year.

And a lot of them underperform even that...

But in the world of biotech, gains this big are not entirely uncommon, ESPECIALLY WHEN IT COMES TO VACCINES.

Vaccines are the holy grail of the biotech industry.

Not only because they're so difficult to develop...

But because a vaccine can cost as much as $725 a dose.

Multiply that number by the BILLIONS of people who need vaccines... 

And you're looking at BILLIONS of dollars in revenue for a single company.  

For larger companies that develop vaccines, this kind of money can keep a business afloat for decades.

For smaller companies, it can produce earth-shattering gains for early investors.

I've seen it more times than I can count:

C_03-05_3-upped grid

When you consider the fact that there are over 9,000 stocks on the market...

These are incredibly rare returns. But in the world of biotech, they're not entirely uncommon either.

C_06_PieChart

The only problem is...

With dozens of companies racing to produce a vaccine right now...

Very few people know...

  • WHICH of these companies is ahead of the game...
  • WHOSE vaccine will likely reach the market first...
  • And HOW long it could take to arrive to your town.  

Well, I Have Answers...

After Governor Gavin Newsom issued a statewide "stay at home" order here in California back on March 19...

I reached out to every CEO, scientist, vaccinologist, and biochemist I could think of.

That's how I found out about this lab – the one you see pictured here...

BR_03_Still of Lab

It's a short drive from my house in Silicon Valley.

Now, this has not made the front page of the news yet...

But the researchers inside this lab have developed an experimental vaccine for the coronavirus.

What's so unusual about this situation...

Is that the company who owns this lab is about 1/200 the size of Pfizer, Merck, and GlaxoSmithKline.

C_07 Bar Chart

And yet, despite their size...

This company is on the precipice of solving the worst health crisis of the last century.

And based on what I've been told, this could all happen at record speed...

According to a member of the company's advisory board – a well-respected immunologist known as the "Godfather of Vaccines..."

Proof that a COVID-19 vaccine works likely will not take a year.

It may not even take six months.

Q_04

We could know the full effectiveness of a COVID-19 vaccine any day now.

In any other situation, I probably wouldn't be so gung ho on a single round of clinical trials.

But COVID-19 isn't like anything we've dealt with before.

It's an all-encompassing virus that's affected nearly FOUR MILLION people.

So news alone that a clinical vaccine can provide immunity from the disease would be monumental.

We know the FDA is taking drastic measures to get viable treatments and vaccines out to the public ASAP.

In fact, just weeks ago, when an experimental COVID-19 treatment, Remdesivir, showed just a slight bit of promise...

Improving recovery times by four days...

And survival rates by 3%...

The FDA immediately enacted a special order allowing for the initial doses of Remdesivir to reach people in critical condition.

As a result, Gilead's stock shot up 10%.

C_08_GILD

That may not seem like a huge jump.

But Gilead is also a $99 billion company.

So let me ask you – once this trial is complete...

What do you think is possible if this tiny lab announces positive results?

I'll tell you what can happen...

This vaccine could go straight to the very people who need it most and send this stock flying into the next hemisphere.

That's why the company is already getting its first million doses ready to ship out before the year ends.

So the question is how did one of the smallest biotech companies in America develop what could be the most lucrative drug in history – a viable vaccine for the coronavirus...

Outpacing 67 other firms, including goliaths like Pfizer, Johnson & Johnson, and Sanofi?

And how could this be your best shot at making 3,000% gains in less time than you ever thought possible?

Let me tell you...

While most labs began studying the coronavirus in late February of 2020, this company had essentially "broken ground" on researching and developing a "vaccine" way back in 2018.

Doesn't make sense, right?

If the coronavirus wasn't widely publicized until a few months ago...

How could this company have started working on a vaccine a year prior?

Well, turns out this company had very successful results with a vaccine for MERS – Middle Eastern Respiratory Syndrome – that was 92% effective in clinical trials.

Why does this matter?

Because MERS and COVID-19 are VERY similar.

They actually both come from the same family of viruses.

GA_03
  • BOTH originated in bats...
  • BOTH cause acute respiratory illness, and...
  • BOTH share nearly the same genome sequences.

That's not just my opinion...

A study from the American Journal of Roentgenology proves that COVID-19 and MERS are "strongly linked."

Radiologists have also determined that the two viruses exhibit "significant overlap."

And if you look at the two viruses side by side, you'll see exactly what I mean.

This is what the MERS virus looks like under a microscope... and again with COVID-19.

GA_04_MERs View

If you ask me, the two look virtually the same.

Now, because these viruses are so closely related...

Developing a viable COVID vaccine may not be as difficult as you think.

So far, any developments in these trials have been under strict lock and key.

Practically nothing has made it to the public eye.

But what I do know is that the CEO is so confident in the outcome of these trials...

He's already announced that the first million doses of the vaccine could be distributed for emergency use before the year is over.

One of the company's scientific advisors elaborated further.

Just before the start of this clinical trial, he announced that a vaccine could be proven viable at "record speed."

To quote him directly he said...

Q_04_v2

Which means if this trial proves the vaccine is viable...

It could go full throttle any day now.

This is the precise news the world needs right now.

This vaccine is the key to pressing the play button on a paused global economy...

And could help in preventing a second and third wave of infections later this year and into 2021.

That's why President Trump has spoken directly with the CEO of this tiny company personally...

To assure the CEO he will give him "any help he needs."

So far, they're already collaborating closely with DARPA, the FDA, the NIH...

And dozens of other organizations – government and private alike...

From the Department of Defense (DoD), The Coalition for Epidemic Preparedness Innovations (CEPI), and the Bill & Melinda Gates Foundation...

To investment banks like BlackRock, Vanguard, and Morgan Stanley.    

Major institutions have dumped truckloads of money into this company's coffers – over $200 million to be exact.

C_09 Pie Chart

And of course, investors stand to make a boatload when it's all said and done.

I can't stress this enough...

This company is tiny.

They're also highly liquid.

In fact, right now on the private Dark Pool exchanges...

Over 30 million shares are trading hands per day.

To give you context, Amazon only averages about six million.

Netflix is right there with eight million.

And even Roche – the second largest biotech company in the world – only trades 1/10 as many shares at three million.

C_10 Traded Shares Comparison

So what I'm saying is this firm is attracting more investors than some of the biggest, most profitable companies in the world.

And this is all happening BEFORE the company has even announced its clinical trial results...

Which means once this company finishes testing and potentially puts out its first doses, their stock could go absolutely, positively INSANE!!!!

That's why this could be such a historic period for this company's shareholders.

When a company of this size develops a vaccine of this magnitude...

Its stock doesn't just go up...

It goes GANGBUSTERS.

When CSL Limited broke ground on a swine flu vaccine that was approved in 2009, its stock tore through the market like an F5 tornado, going up 980%.

C_11_CSLLY

When Akorn Pharmaceuticals got the green light from the FDA for a tetanus vaccine, their stock went haywire, rising 7,721%.

C_12_AKRX

When Bavarian Nordic developed a smallpox vaccine – IMMAVUNE – its shares flew up 991%.

C_13_BAVA

Do gains like these happen every day?

Of course not.

These are once-in-a-lifetime profits.

The kinds of profits that no ordinary biotech can guarantee.

But that's why this is such an exciting situation.

Because this is no ordinary biotech play...

And this company is no ordinary biotech stock. Is there still a risk here? Of course, there is.

I'm not saying you should invest your entire 401(k) – or money that you can't afford to risk – in a coronavirus vaccine.

But what I am saying is that opportunities like these come along maybe once every 50 years, if that.

Like I said earlier, in the biotech world...

Vaccines are the holy grail.

And by investing in them BEFORE they make their commercialized debut...

You can literally make enough money that you may never have to invest in anything else for the rest of your life.

And mind you...

These companies I just showed you...

C_11-13 3-upped Chart grid

They developed these vaccines when the global economy was actually functioning.

Therefore, they weren't nearly as important or as urgent as the coronavirus vaccine is.

That's why I believe this company could be one of the biggest game changers I've ever seen. 

And that's coming from a guy in his 60s who has seen more ups and downs in the stock market than Nicolas Cage's career...

But has still managed to publish 283 double- and triple-digit winning investment opportunities over the years.

With the coronavirus in full swing...

And top medical experts now saying that a vaccine is the ONLY viable solution...

This Tiny Company Could Be Developing the Most Lucrative Vaccine of All Time.

One that could see global demand soar north of 100 million...

Even one billion doses over the next year.

But this company doesn't need to sell anywhere close to one billion doses.

Based off the company's most recent revenue figures...

A million doses alone could mean an estimated 2,404% sales surge for this tiny firm.

How do I know all this?

My name is Michael Robinson...

Michael Robinson headshot

And if there's one thing you should know about me it's that whenever I investigate a new situation in the investing world...

I do the one thing no one else wants to do...

I interrogate, investigate, and probe every player in every situation.

Why? Because if you truly want to make money in a world where everyone has access to the same information at the same time...

You can't wait until a story leaks out on the internet.

You have to go directly to the source...

In order to extract information BEFORE it finds its way onto Twitter and Facebook.

And I'll talk to anyone to get the answer I'm looking for...

CEOs, CFOs, CIOs, directors, comptrollers, institutional investors, salesmen, interns, janitors, politicians...

No one is off-limits.

And I don't take NO for an answer.

Back in early 2014, I hunted down the CEO of this tiny company I've been telling you about.

We wined and dined for hours at a swanky restaurant in San Francisco, just a stone's throw from the Bay Bridge.

I didn't do this for my own enjoyment.

I was there to gather information and ask questions.

Because when you actually sit down with people and drill them under a microscope (like I do)...

The truth rises to the surface.

It was during this dinner that the CEO told me about how his company was on the precipice of developing a secret weapon...

A proprietary DNA technology that can help his firm develop vaccines nearly 10 times as quickly as his competitors. 

To understand how this DNA technology works, you first need to understand modern-day vaccines.

The funny thing about what I just said is there's really nothing "modern" about today's vaccines.

In a world where we have some of the most unbelievable medical technologies like...

CRISPR gene editing...

3D-printed artificial organs...

And robotic surgeries...

Guess how we make vaccines...

Chicken eggs.

We Literally Grow Vaccines Inside Millions of Chicken Eggs.

This has been the industry standard for over 70 years now.

BR_06

And while the entire medical industry has charged forward at an exponential rate...

This vaccine technology got left behind...

Seemingly, somewhere on a chicken farm in Iowa.

So the obvious question is...

If Chicken Eggs Work, Why Do We Need to Upgrade Vaccine Technology?

The answer is time.

It takes time to develop new vaccines with chicken eggs.

Just think about it...

When you're making vaccines out of millions of chicken eggs, you've got a massive supply chain hurdle.

BR_07

According to a representative from the Biomedical Advanced Research and Development Authority in Washington D.C...

In a pandemic situation, you need a constant supply of 900,000 chicken eggs a day for six to nine months to supply the U.S. with a vaccine.

Next, you need to inject all these eggs with the virus.

How do you do this?

One by one...

BR_08

As you can imagine, this takes forever.

Because not only is it a HUGE waste of resources...

But you can't just have anyone do this.

It's not as easy as it looks.

You need highly trained lab techs with medical degrees.

We're talking about someone who just spent the last four years at Harvard, Johns Hopkins, or UCLA.

For months, these people will inject hundreds of thousands of chicken eggs with vaccines.

Then you have to incubate them to see if a vaccine can even grow.

This whole process can EASILY take six months.

So Do We Really Have Six Months to Wait?

Of course, not...

That's where this company's new DNA technology comes into play.

Instead of spending six months on this process...

This DNA technology can take a snapshot of the virus.

And by using computer algorithms, it can "decode the puzzle" behind these viruses...

And render what could be a viable vaccine in less than a day...

Without a single chicken egg!!!

BR_09

Compare that to the months it would take to create this vaccine the old fashion way, and something becomes crystal clear.

It Shouldn't Take 18 Months for an Effective Coronavirus Vaccine to Hit the Market...

Not Even Close.

Normally, I would NEVER say something like this.

But we're not in a normal situation, not by a long shot.

Not only has the FDA issued a new policy to help expedite the delivery of a coronavirus vaccine...

But there's also an FDA work-around that exists which allows clinical vaccines to be sold during pandemics.

In other words, even if this vaccine – for whatever reason – doesn't get full approval by the FDA...

It Could Still Save the Lives of MILLIONS of People.

What I'm referring to is called an Emergency Use Authorization – or EUA.

And while pretty much no one knows about this measure hidden within the FDA's guidelines...

It's actually been in effect since 2004.

That's when the very first Emergency Use Authorization was enacted for an anthrax vaccine – BioThrax.

IMG_03

At the time, the FDA had never formally approved it.

But with the small amount of data that we had on this vaccine, the results looked incredible.

And for an imminent biological threat like anthrax, waiting years for the normal FDA procedure could have meant thousands of deaths...

Avoidable deaths too, considering the vaccine looked so promising.

That's why the FDA ultimately allowed the drug to be released in a very short time relative to the normal process.  

The Secretary of Defense for Health Affairs put it best, stating...

"The benefits of the vaccine far outweigh the risks."

That was just the beginning of what made this story so noteworthy.

The really incredible piece is what followed shortly after...

When Emergent BioSolutions, the company behind this vaccine, signed an agreement to deliver 18 million doses to military personnel...

IMG_04

The stock went berserk.

Going up 490% in less than a year.

C_16_EBS

Keep in mind...

This vaccine was for anthrax.

Anthrax is a scary and deadly disease, no doubt.

But there have only been five documented anthrax deaths in U.S. history.

And yet this company is STILL riding a high from this EUA.

And they aren't the only one. In fact...

The FDA Has Issued an EUA for Every Major Pandemic Since the Anthrax Scare.

On October 10, 2014, they issued an EUA for the Ebola virus.

On July 17, 2015, they issued an EUA for MERS.

On February 26, 2016, they issued an EUA for the Zika virus.

And on March 13 of this year, the FDA issued an EUA for COVID-19...

GA_06 – 4-Upped Grid of Stills?

That's why we've already seen test kits, new treatment drugs, and medical devices like respirators flood the market.

Many of these items have NOT been approved by the FDA to be used on COVID-19.

But they're all getting the green light anyways.

Because the government, the FDA, and the pharmaceutical companies...

They all know these are not normal times.

And the normal FDA process just isn't going to cut it.

In other words, this company doesn't NEED to go through the normal FDA hurdles...

It just needs to prove that its vaccine works...

If it can prove this...

It Can Expect to Distribute Its Vaccine as Soon as Possible – Without Getting Normal Approval.

In fact, they're already working with large-scale manufacturers so that when the time comes...

They can get the FDA Emergency Use Authorization and hopefully have millions of doses ready to be fully tested.

Those approved doses could then be shipped and deployed to critically ill patients all over the world.   

When that happens...

This could easily become one of the biggest stock stories of the century...

According to the CEO of CEPI, one of the largest global health coalitions dedicated to fighting infectious diseases...

Within two years...

Potentially up to Seven BILLION People Will Need to Be Vaccinated for COVID-19.

And how much do you think a single vaccine is going to cost?

$15... $100... $200?

Try again.

TIME magazine and the New York Times both published an op-ed suggesting a COVID vaccine could cost $500!!!

Q_12 Article Headline

Based on the U.S. population alone, that could yield up to $165 billion in revenue.

That's why the New York Times doubled down on this, calling a COVID-19 vaccine...

"Potentially one of the most profitable drugs in history."

That's huge.

Especially for a company that makes less than $10 million a year and primarily operates off grants and government funding.

Imagine if they come out on top with a vaccine that works.

It should be easy to grasp what even a small piece of that windfall would look like for a company this tiny.

And that's if it sells each vaccine dose for $500.

However, I'm a realist, not a sensationalist. 

I've gotten a look at documents with CDC vaccination pricing...

And even though the media may tell you this vaccine will cost $500, I'm expecting it to cost around $103 – give or take.

At that rate – with just one million sales – this company could still have a potential $103 MILLION revenue surge.

C_17

What does that mean for investors who get in now – before this company races towards the goal line?

Well...

When you factor in this company's price-to-sales trajectory, this giant injection of cash would bump shares by an estimated 758%.

Meaning if you put $5,000 into this company today, it could quickly turn into over $42,000 in less time than you thought possible.

C_18 – just $42,000 sample

$10,000 could multiply into $85,000...

$100,000 could explode into $855,000 – you get the point.

That would be life-changing money.

And if all goes according to plan, that's only in the short term.

Over the long term, we could see billions of these vaccinations ship out on a global scale, the likes of which we've never seen in human history.

So that means this number could easily grow 10-fold.

But I'll be up front with you...

I may be the top-rated tech investing expert in America with 283 double- and triple-digit winners in my arsenal...

I may know how to gather information better than anyone...

But I can't see the future.

The stars are aligning for this tiny company, no doubt about that.

But in the world of biotech, we're always shooting for the moon.

And even with the best of the best biotech companies, sometimes we don't ALWAYS reach that target.

That's why I said it, and I'll say it again...

You NEVER want to put more than you can afford to lose on the line...

Because acts of God can happen to even the best-looking investments.

The good news is...

Even if this biotech company doesn't "reach the moon" on this one...

My expert opinion is that they're still going to take off into orbit.

And by that, I mean...

You Can Still Make 10 Times Your Money.

C_19-21 3-Upped Chart Grid

Unlike other stocks, biotech stocks are fueled by progress.

Every time a drug passes through one of the FDA's rigorous phases and inches itself closer to approval...

That's "progress."

It's proof that the company has what it takes to get a drug to market.

It's like one of those Tough Mudder competitions.

BR_11

Only a small percentage of the people who participate in these insane races make it to the finish line...

But for the people who participate in these events...

It's not about crossing the finish line.

It's about seeing how close you can get to the finish line.

For biotech companies, the FDA's five-stage approval process is a Tough Mudder obstacle course.

IMG_01 revisit

Every phase is a new obstacle...

Every obstacle is a new victory...

An opportunity for these companies to prove their self-worth, and attract investors – which in turn, contributes to bumping up the share price.

As you can see...

C_22-24 3-Upped Chart Grid

Anytime a company passes through one of these phases, its stock jumps.

And with something as urgent as COVID-19, I can tell you with confidence...

It doesn't matter if it's Phase 1... Phase 2... Phase 3... or preclinical trials...

If a week from today this company announces positive results in their human trials...

The stock isn't just going to sit dormant...

I think it's going to explode like an atomic bomb.

That's why you have to act now before these results are announced.

By that point, it could be too late.

It only takes a matter of days for these stocks to jump 100%, 200%, or even more...

And I don't want you to miss out.

My mission is to uncover opportunities in their infancy before the rest of the world catches on.

That being said, it shouldn't surprise you that I just talked with the CEO of this tiny company once again...

Although this time we weren't at a swanky five-star restaurant overlooking the Pacific.

We were in our homes talking over Zoom like everyone else.

I was blown away by the information he told me.

Because it could have some incredible implications for this company's next steps...

Namely – why I think they could be skyrocketing off good news in a matter of weeks.

Now, the best part about our meeting?

I Recorded This Entire Interview.

In fact, I'm uploading it to the cloud right now.

In a few minutes – if you're interested – I'll tell you how to get an email with a secure link to access it.

When you hear this, it's going to blow your mind.

What this company is doing – working around the clock to get a viable vaccine to the public – is truly amazing.

This whole situation is lining up to become one of the greatest American success stories of all time.

And I want to share all of it with you.

I will also be attaching a file that contains every tidbit of information I've gathered in the last few weeks.

I encourage you to read it.

It contains information about this company that I doubt you've seen.  

I've even included specific buy and sell instructions inside.

This way, you're not scratching your head guessing what price to buy at...

Or stranded on third base when it comes time to sell.

All of that analysis is done for you.

Rest assured this is more than just my opinion.

This file also includes information that comes from the inner echelon – the people that are closest to this situation.

This is the advantage of living in Silicon Valley, California.

In the Valley (as we call it), you can network with the smartest tech entrepreneurs, investors, and risks takers on the planet...

Guys who often end up becoming CEOs of companies like Apple, Cisco, eBay, Google, HP, Intel, and Yahoo!

That's why I live here...

To be close to the action.

It's also why I've never had a losing year and relentlessly outperform my peers by a country mile.

I don't wait until information becomes headline news.

I get my data directly from the source.

And I share this information with those who understand that when it comes to making money in ANY market at ANY time...

There's ONLY one sector worth paying attention to – the tech sector.

I call our group the Nexus-9 Network.

I started this group with a single goal in mind...

To prove that when it comes to making money...

Technology always reigns supreme.

We can be in a bear market... bull market... recession... or boom.

Technology never stops evolving.

Society is always looking for...

  • Better ways to communicate...
  • Quicker solutions...
  • Faster internet speeds...
  • Stronger defense systems...
  • Easier access to data...
  • Cutting-edge entertainment...

And in situations like these...

  • Advances in medical technology.

This is why the TECH sector has crushed every other sector for years.

As you can see...

C_33

It's why more and more people are becoming billionaires by making mobile apps, enterprise software, and renewable energy products.

And why technology may be the ONLY way you could achieve life-changing gains over and over again.

I know that's a bold claim...

But I have the track record to prove it.

List_05

I've had some losses, sure. Who hasn't?

But my losses have never been big.

Even this year as thousands of stocks plummeted and the market tanked by 30%...

My biggest loss was recorded at only -25%.

What's my secret?

I target companies when hardly anyone knows who they are.

Here are just some of the winners, including partial closeouts...

Then one day, when they unleash their technologies on the world – BOOM.

They come out of left field, blindsiding the market and posting incredible profits.

These are the companies we hunt down in the Nexus-9 Network.

nexus9

It's not easy.  

With tiny companies like these – to get in at the perfect time when they're still just little specks on the map...

You really need to be right at the epicenter of the situation – and you have to have your finger on the pulse of every little move these guys are making.

Let's be real...

These little tech firms aren't on CNBC... they aren't plastered all over the Wall Street Journal...

The ONLY Way You Get In on Early-Stage Tech Firms like These Is by Knowing People.

And that's where I come in.

I go out and find the CEOs... venture capitalists... whoever's behind these projects...

And I set up meetings in San Francisco – coffee, lunch, whatever.

I Go Straight to the Source for My Information...

WYG_01 Alert

And when I find one of these BIG opportunities...

I write up every detail and relay everything to paying members of the Nexus-9 Network.

This group is my livelihood.

In so many words, we focus on the nine most exciting industries within the tech sector...

GA_10

I do everything I can to cover every detail of every situation I come across by providing.

  • Catalysts...
  • Contracts...
  • Scaling strategies...
  • Distribution methods...

And of course, I always include immediate price targets for all members of the Nexus-9 Network...

WYG_02 Buy and Sell Alert
  • When to buy...
  • When to sell...
  • All of my research and analysis, and...
  • When to keep some money on the table.

I never leave this group in the dark about anything.

And of course, I'm not biased.

The only reason I ever recommend a company to my readers is because I feel strongly about the potential it offers.

I also include a Virtual Deal Briefing with every recommendation I send out to subscribing members of the Network.

WYG_03 Virtual Deal Briefing

These are exclusive conference calls I conduct where I expand my reasoning behind every target...

It's where I really dig into the details.

And speaking of details...

I've spent the past 30 minutes telling you about the one company that I believe is going to be first to market with a vaccine for the coronavirus...

And could produce up to 3,000% gains for folks in the process.

But if you think that only one company is going to benefit from this unprecedented situation, think again...

There Are Two MORE Vaccine Candidates Entering Clinical Trials...

And I'm Watching BOTH like a Hawk.

Normally with one firm so far ahead, I wouldn't be telling you about the second and third best.

But due to the situation and the UNPRECEDENTED demand for as many as seven billion doses of a COVID-19 vaccine...

There's some room, at least for the next year, for these three companies to coexist simultaneously.

Ultimately, we see our number-one pick as edging these other two out of the race.

But like I said before...

In the world of biotech, it's not about winning...

It's about making progress.

And whenever a company moves from one phase to the next... that's making progress!

Given the current global demand for a vaccine for COVID-19...

And the FDA's attempt to expedite delivery...

ANY vaccine company showing some competency in clinical trials is in position for a price explosion.

It's already happening...

On April 6, GenMark Diagnostics (GNMK) blasted off...

C_25_GNMK

Rising 157% in the next three weeks.

On the week of April 13, Moderna shot up 68%...

C_26_Moderna

On April 15, Regeneron (REGN) shot up and spiked 12% in 72 hours.

C_27_REGN

These are big companies...

The kinds of companies that rarely ever produce double-digit gains over the course of a year, let alone a few days.

But like I keep saying, we're not living in normal times.

These companies – and many others like them – are rising fast because BILLIONS of people are now relying on them.

Which means it doesn't even matter which of our candidates gets to the finish line first...

They could all soar in price.

One of These Candidates Has NEVER Had a Drug Approved...

And yet, they're still worth over $1 billion.

Most investors would look at a clinical-stage firm like this and never buy in, including myself.

But this company has made incredible progress in the last six months.

Last year, they were working on their Ebola and Influenza vaccines...

And now as they enter clinical trials for a COVID-19 vaccine...

The number of shares changing hands each day has grown exponentially.

At the end of last year, the daily volume sat at about 730,000 shares...

As of last week, that spiked to over 27 million shares.

C_28 Volume Chart

That's a little more than a 30-fold increase.

And in my experience, when you have 30 times the number of investors demanding shares of a single stock...

The price goes up, FAST.

Truth be told, this stock could light up like a Christmas tree any day now.

They just announced that their preclinical trials with animals were very successful...

And while they're a little bit behind our number-one pick in terms of getting approval from the FDA...

They're about to test their vaccine on humans. And they're expecting to announce the results of those trails in July.

If this goes anything like their other vaccine trials...

The stock could jump 213% within a week.

Our third vaccine play is in a similar position.

They're just working on something a little bit different...

An Oral COVID-19 Vaccine.

What does that mean?

If you've ever gotten a flu vaccine, it's usually a shot, right?

Well...

When you're dealing with shots, there's a lot of inventory that needs to be micromanaged.

Syringes for example.

You can't reuse syringes...

So for a COVID-19 vaccine, if we need seven billion doses, that's seven BILLION syringes.

Plus, with the actual vaccine itself, it's perishable.

So that means it needs to be stored at the perfect temperature while it ships all across the globe.

BR_14 Still

That means refrigerated storage facilities... refrigerated trucks...

You get the picture.

There are a lot of different things to consider.

And it can all add up to one big headache.

That's why this third company that I'm eyeing is an extremely unique play in the vaccine sector.

Because they're ditching this whole injection-based model...

And instead, opting for an oral delivery system...

Where you can literally take a pill, swallow it, and that's it – you have the vaccine inside your body.

Who would say no to that?

  • No doctors' visits.
  • No long lines at the pharmacy.
  • No soreness in your arms.
  • No scary, painful needles.

You would just open your mailbox...

See a bottle of tablets sitting inside...

Swallow one, and you're now vaccinated from the coronavirus.

That's why this oral vaccine player is catching some serious attention.

They've already proven that their tablet technology works.

In 2014, they manufactured an H1N1 vaccine tablet that was equally as effective as an injectable.

GA_12 Results Image

And now, they're looking to replicate these results for COVID-19.

In fact, just days ago, they announced their preclinical results, and it was a resounding success.

All the animals they tested were immune to COVID-19 within two weeks of vaccination.

Any day they could start testing their oral vaccine on humans.

Once the results come in, I'm expecting early investors to collect 420% potential gains on the low end.

But if this company's oral vaccine technology picks up steam...

Which I fully expect it to...

You could be looking at 2,000% gains or more.

I've streamlined everything you need to know about all three of these urgent vaccine plays.

It's All Inside My COVID-19 Investor's Portfolio.

WYG_04

Inside this portfolio, you're going to get a complete guide on how to invest in all three companies I've told you about today...

  • Our "gold medalist" in this race is the tiny company that has had a two-year "head start" developing a COVID-19 vaccine and could make you 3,000% gains.
  • Our "silver medalist" is developing an oral version of the coronavirus vaccine and could make you up to 2,000% gains.
  • Our "bronze medalist" is working on a COVID-19 vaccine that is being tested on animals. If results from these trials are positive, you could be looking at another 213%.

All in all, the information in this COVID-19 Investor's Portfolio is the most comprehensive, action-packed analysis and research I've ever put together for any situation in my career.

It covers ALL of the ins and outs to this once-in-a-lifetime situation...

Without any medical or investing jargon.

It's all simple and easy to understand.

And I want to get this into your hands ASAP.

In fact, I'm going to press the send button as soon as I stop recording.

That means in just a minute or two, you can dive right into this for yourself.

But before I send this to you...

I'm going to ask you to do one simple thing, and that is to subscribe and...

 Add Your Name to the Nexus-9 Network.

I already told you a little bit of what our group is all about – and I'll say it again.

We acknowledge a simple truth...

That when it comes to consistently making money in the stock market...

The tech sector reigns supreme!

And as the founder of the Nexus-9 Network...

My job is to weed through the thousands of Silicon Valley startups out there...

And decide which of these companies is worth targeting.

I funnel all of this information straight to our subscribing members in the most streamlined manner possible...

So that everyone can see how to invest in these stocks LONG before they become headline news and their share prices potentially explode.

In 2016, I recommended a small payment processing company named Square to our group.

GA_13 Square Logo paired with Alert WYG?

At the time, this little-known San Francisco firm was actually down from their IPO.

But I knew at around $9, it was the PERFECT time to strike.

So I sent out an alert to my subscribers that they should act on this opportunity.

I probably don't have to tell you what's happened since...

Nowadays, you see Square point-of-sale systems at restaurants, concerts, sporting events...

And their stock price has BOOMED.

I informed all my readers to sell their remaining shares at $65.45 for a 560% gain...

C_29_SQ

Before that, I gave members of the Nexus-9 Network the chance to make 271% by selling half their position in NVIDIA...

C_30_NVDA

And 299% on the last half of their Zendesk position.

C_31_ZEN

My subscribers even got a chance to invest in Array BioPharma – a small cancer treatment company – back in 2012.

GA_14 Array Logo paired with Alert WYG?

At that time, the stock was just about $5.

Fast-forward to last year when they got bought out by Pfizer, and their stock shot up to just shy of $48.

I recommended to close this one out a little early...

But it could've been a 794% gain for anyone who rode this out until the end!

C_32_ARRY

It's early insight on opportunities like these that makes my research so prosperous for so many people.

Some readers have made TENS OF THOUSANDS – EVEN HUNDREDS OF THOUSANDS OF DOLLARS from a single investment.

List_07 – NOT animated/scrolling

A lot of people don't make that kind of money over the course of a decade, let alone from a single investment.

But this is what separates the Nexus-9 Network from everything else out there...

List_08

We LOVE technology...

Because market history has shown us that when tech stocks go up, they can produce epic gains that no other companies can.

If you choose to join my group...

I can also show you how to potentially "supercharge" gains like these by using options.

But this is just the beginning.

If there's one thing I can tell you about Silicon Valley...

Every day, no matter what the state of the world is, new technologies are always emerging.

And multibillion-dollar VCs are cutting bottomless checks to get in on them.

My goal – pandemic or not – is to tap into this 24/7 hustle and bustle...

And keep the money flowing your way – no matter what.

WYG_05 Investor's Deck

That's why every single week, I'm going to put together a brand-new Nexus-9 Network Investor's Deck for you.

Here's how it's going to work...

The second I decide it's time to pull the trigger on one of these tech plays, I'm going to let you know.

First, it's going to be via an email alert.

Inside this alert, I'll give you a quick write-up about the company, what they're doing, and why I'm expecting a HUGE uptick in share price just over the horizon.

WYG_06 Cell Phone Text Notifications

If you're anything like me, you're on your phone constantly.

If that's the case, I'm happy to text you whenever I issue a new alert as well. 

That way, you don't have to refresh your inbox every five minutes.

Then after I send out an alert...

I'm going to take you even deeper into the specifics of every opportunity...

By Saving You a Seat to Take Part in Weekly Trading Calls.

I'm a firm believer that knowledge is power...

I also believe knowledge without action is just about the biggest mistake anyone can make.

WYG_07 Strategy Room

That's why I set up our Nexus-9 Strategy Room.

Every week, once I decide which company we're targeting, I'll send out an invite to the entire group. 

This link will give you access to a private digital space where Nexus-9 subscribers "huddle" together.

The minute the clock strikes and the meeting starts, we'll all pile into this call and get STRAIGHT to business.

I share my screen and show you what I'm seeing.

Whether that's financials...

Volume charts...

And sometimes, if scheduling permits, I'll even bring guests inside our Strategy Room.

CEOs, policy makers, venture capitalists – any third party that might be even closer to the situation than myself.

Not only do we cover all angles from a financial standpoint...

But I often give trading demonstrations as well.

I'll tell you what price you should buy shares for, when to buy more, when to sell, and when to take any profits off the table.

Plus, we'll explore option chains on some of these opportunities if you're looking to "level up" your profits.

Every time we enter the Nexus-9 Strategy Room, you're going to learn a TON.

And at the end of each call...

WYG_08 Portfolio Update

I'm going to do a selective portfolio update regarding any companies that are breaking ground on key developments.

That way, you are ALWAYS up to date on the most active companies in our model portfolio.

And I'm going to tell you exactly how each of these positions is doing every week.

Remember: With the Nexus-9 Network, I'm showcasing a new opportunity each week.

That means over the course of your one-year membership...

WYG_09 Package Shot? Array of issues?

You Could Be a Ground-Floor Investor in as Many as 52 of the Most Innovative Tech Disruptors.

All you need to do to subscribe is click the JOIN TODAY button at the bottom of this screen...

And you'll be a few details away from subscribing to the Nexus-9 Network...

WYG_10 Web Portal

Which also includes unlimited access to the Nexus-9 Web Portal and Live Tracking Portfolio – so you can see every open position.

And of course, there's one more fundamental component of this whole thing – YOU.

Nexus-9 Network is a close-knit group.

A blended family.

We pride ourselves on communication...

Because we know that in the world of technology...

Things move fast. 

WYG_11 Nexus-9 Network forum page

That's why we have a members-only message board on our web portal... so that you and everyone else can continue the conversation 24/7 without interruption.

You might even find that there are a few subscribers in your area.

Who knows?

Maybe once a vaccine gets to market and we put this nightmare behind us, you can start your own private Nexus-9 Network...

And meet for lunch or have a drink with people who love technology.

What I really want you to understand here is that the Nexus-9 Network is NOT an investment blog...

Or some financial channel on TV...

We Are a Tribe.

All of us have a like-minded goal...

To make a ton of money investing in technology.

And now's the time.

Obviously, admission to the Nexus-9 Network isn't free.

But the only way you're going to find out the price is by clicking the link below.

You'll be taken to a secure page where you can complete your membership order form...

And "lock in" your spot in the Nexus-9 Network.

I can't wait for you to get started... just click the link below.

If you have any questions about the service and how it will work for you, I encourage you to contact our reliable customer service team at 855-509-6600 or 443-353-4770 (for international calls) and mention Priority Code: WTIMW518.

Once again, I want to thank you for joining me today.

And more importantly, stay safe.

May 2020